PMA
TMO icon

Prudent Man Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Prudent Man Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
2,549
+873
+52% +$474K 0.38% 63
2025
Q4 		$971K Sell
1,676
-39
-2% -$22.1K 0.35% 59
2025
Q3 		$832K Sell
1,715
-218
-11% -$101K 0.31% 66
2025
Q2 		$784K Buy
1,933
+473
+32% +$198K 0.25% 92
2025
Q1 		$726K Buy
1,460
+32
+2% +$17.3K 0.26% 88
2024
Q4 		$743K Sell
1,428
-128
-8% -$70.4K 0.27% 80
2024
Q3 		$962K Sell
1,556
-93
-6% -$55.1K 0.32% 74
2024
Q2 		$912K Buy
1,649
+61
+4% +$34.9K 0.32% 73
2024
Q1 		$923K Sell
1,588
-1,551
-49% -$870K 0.35% 69
2023
Q4 		$1.67M Sell
3,139
-127
-4% -$61.5K 0.62% 26
2023
Q3 		$1.65M Sell
3,266
-262
-7% -$140K 0.66% 21
2023
Q2 		$1.84M Sell
3,528
-63
-2% -$34K 0.69% 21
2023
Q1 		$2.07M Sell
3,591
-48
-1% -$27.1K 0.81% 17
2022
Q4 		$2M Buy
3,639
+531
+17% +$281K 0.81% 16
2022
Q3 		$1.58M Sell
3,108
-220
-7% -$123K 0.75% 19
2022
Q2 		$1.81M Buy
3,328
+302
+10% +$166K 0.84% 16
2022
Q1 		$1.79M Sell
3,026
-73
-2% -$41.9K 0.72% 20
2021
Q4 		$2.07M Sell
3,099
-351
-10% -$219K 0.79% 19
2021
Q3 		$1.97M Sell
3,450
-56
-2% -$30.7K 0.75% 20
2021
Q2 		$1.77M Buy
3,506
+211
+6% +$99.6K 0.68% 23
2021
Q1 		$1.5M Buy
3,295
+125
+4% +$59.7K 0.63% 29
2020
Q4 		$14.8M Sell
3,170
-102
-3% -$47.8K 6.19% 3
2020
Q3 		$1.45M Sell
3,272
-60
-2% -$24.8K 0.77% 21
2020
Q2 		$1.21M Buy
+3,332
New +$1.12M 1.07% 19

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Prudent Man Advisors's TMO Position: Q1 2026 in Review

Prudent Man Advisors increased its Thermo Fisher Scientific (TMO) stake by 52% in Q1 2026, buying an estimated $474K and bringing the position to 2,549 shares worth $1.25M. The position accounts for 0.38% of the portfolio, ranked #63.

Prudent Man Advisors first reported a position in TMO in Q2 2020 and has held it in 24 quarters since. The position peaked at $14.8M in Q4 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Prudent Man Advisors held 2,549 shares of Thermo Fisher Scientific worth $1.25M as of Q1 2026.
  • Prudent Man Advisors bought 873 Thermo Fisher Scientific shares in Q1 2026, an estimated $474K.
  • Thermo Fisher Scientific made up 0.38% of Prudent Man Advisors's portfolio in Q1 2026, its #63 holding.
  • Prudent Man Advisors first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 24 quarters since.
  • Prudent Man Advisors's Thermo Fisher Scientific position peaked at $14.8M in Q4 2020.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.